Public statement: Baraclude (entecavir): Occurrence of a resistant HIV variant in a patient co-infected with HIV and HBV

View source ↗

Summary

EMA public statement about the occurrence of a resistant HIV variant in a patient co-infected with HIV and hepatitis B while on Baraclude (entecavir).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)